Assessment of the HIV-1 viral reservior following chemotherapy in HIV-1 infected patients (360G-Wellcome-098251_Z_12_Z)
An HIV vaccine remains elusive, and there are serious doubts as to whether large scale antiretroviral therapy can be maintained. Curative strategies are therefore now being explored. These approaches require an understanding of theHIV reservoir. I wish to explore the impact of stem cell transplantation and/or cancer chemotherapy, on markers of HIV replication, to understand the site of the reservoir, and the nature of viral re activation in vivo.
Where is this data from?
This data was originally published by The Wellcome Trust. If you see something about your organisation or the funding it has received on this page that doesn't look right you can submit a grantee amendment request. You can hover over codes from standard codelists to see the user-friendly name provided by 360Giving.
Grant Details
| Amount Awarded | 70000 |
| Applicant Surname | Watters |
| Approval Committee | WT/NIH Four Year PhD Programme Advisory Committee |
| Award Date | 2012-01-30T00:00:00+00:00 |
| Financial Year | 2011/12 |
| Grant Programme: Title | WT/NIH Four Year PhD Studentship |
| Internal ID | 098251/Z/12/Z |
| Lead Applicant | Ms Sarah Watters |
| Partnership Name | Wellcome Trust-NIH PhD Studentships |
| Partnership Value | 70000 |
| Planned Dates: End Date | 2016-09-23T00:00:00+00:00 |
| Planned Dates: Start Date | 2012-09-24T00:00:00+00:00 |
| Recipient Org: Country | United Kingdom |
| Region | Greater London |
| Sponsor(s) | Prof Deenan Pillay |